Mumbai based nutraceutical ingredient player OmniActive Health Technologies Ltd. concluded a round of private equity funding from Everstone Capital and debt funding from multiple sources including Avendus Finance Private Limited (AFPL), the credit solutions arm of Avendus Group.
OmniActive is a leading supplier of naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical companies that provide food supplements and nutritional fortification. OmniActive has a research-driven approach, state of the art manufacturing facilities, well-equipped R&D centres across India and Canada, and sales and marketing presence across the US, Europe and Asia.
Mr. Sanjaya Mariwala, the Promoter and Managing Director of OmniActive said, “We welcome this partnership with reputed financial investors. With the support of their experienced teams and funding, OmniActive looks forward to building on our history of solid organic growth by further strengthening our presence globally using innovative products and technologies. This will be done by also growing inorganically, to bring a wider product portfolio of responsibly made ingredients to our customers through our strategic acquisitions.”
Mr. Preet Singh, Executive Director at Avendus Capital said, “We believe that there is a large, growing, opportunity in the global nutraceutical space. OmniActive, with its strong R&D and technology platform, leadership positions in segments of choice, and a strong sales and marketing engine, is uniquely positioned to leverage on the opportunity. The partnership with Everstone gives OmniActive a strong runway to execute its growth plans.”
Mr. Sandeep Thapliyal, MD & CEO at AFPL said, “Considering the size of the current opportunity and OmniActive’s future plans, a balanced capital structure was required to empower it to successfully pursue its growth strategy as well as keep the necessary flexibility for the future fund raising. We are happy to provide a solution in line with the desired outcomes for all stakeholders.”
Avendus Group was the sole financial advisor to OmniActive on this transaction.
About OmniActive Health Technologies Limited
OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients. The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies. OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. Clinical research–geared towards demonstrating efficacy and claim substantiation–is the cornerstone of OmniActive’s R&D activities. The company’s centres of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India. Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.
For more information, please visit www.omniactives.com
About Everstone
The Everstone Group is a premier India and Southeast Asia focused private equity and real estate investment firm with assets under management of USD 3.3 billion. Everstone has over 200 people working across six offices—Singapore, Mumbai, Delhi, Bengaluru, Mauritius and London. The firm’s strong presence and network in India and Southeast Asia allows its existing and new portfolio businesses to build operations in the region and beyond. Everstone has been awarded ‘Private Equity Firm of the Year in India’ by Private Equity International for five consecutive years from 2011 to 2015.
For more information, please visit www.everstonecapital.com
About Avendus Group
The Avendus Group (Avendus) is a leading provider of financial services with an emphasis on customized solutions in the areas of Financial Advisory, Wealth Management, Structured Credit Solutions and Alternative Assets Management. Avendus relies on its extensive experience, in-depth domain understanding and knowledge of the regulatory environment, to offer customized solutions that enable clients to meet their strategic aspirations. Avendus Capital has consistently been ranked among the leading financial advisors by overall number of deals. It has a strong track record of cross-border transactions and has helped multiple clients benefit from opportunities across geographies. Avendus’ wide range of clients is testimony to its ability to serve corporate clients throughout their life cycle – from growth funding at an early stage to complex, large sized transactions later in the cycle.
Avendus Finance Pvt. Ltd. specializes in providing highly customized structured credit solutions to Indian entrepreneurs and businesses. Avendus group’s deep domain knowledge stemming from its leadership position in the advisory business and superior credit understanding within the NBFC allows it to underwrite innovative credit solutions for complex deals.
Avendus Capital Inc. and Avendus Capital (UK) Pvt. Ltd. located in New York and London respectively are wholly owned subsidiaries offering M&A and Private Equity syndication services to clients in the respective regions.
For more information, please visit www.avendus.com
